Investigational New Drugs,volume 25,issue 1  (02-2014)

Period of time: 2014年1期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 25,issue 1

Menu

In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

By Brandon Esther,Sparidans Rolf,Ooijen Ronald,Meijerman Irma,Lazaro Luis,Manzanares Ignacio,Beijnen Jos,Schellens Jan in (2007)

Investigational New Drugs,volume 25,issue 1 , Vol. 25, Iss. 1, 2007-02 , pp. 9-19

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: Result of a dose-intensity study

By Parra Hector,Cavina Raffaele,Latteri Fiorenza,Campagnoli Elisabetta,Morenghi Emanuela,Torri Walter,Brambilla Giorgio,Alloisio Marco,Santoro Armando in (2007)

Investigational New Drugs,volume 25,issue 1 , Vol. 25, Iss. 1, 2007-02 , pp. 57-62

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

By Denduluri Neelima,Lee James,Walshe Janice,Berman Arlene,Vatas Ujala,Chow Catherine,Steinberg Seth,Cox Michael,Low Jennifer,Swain Sandra in (2007)

Investigational New Drugs,volume 25,issue 1 , Vol. 25, Iss. 1, 2007-02 , pp. 63-67

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma

By Vaishampayan Ulka,Heilbrun Lance,Shields Anthony,Lawhorn-Crews Jawana,Baranowski Karen,Smith Daryn,Flaherty Lawrence in (2007)

Investigational New Drugs,volume 25,issue 1 , Vol. 25, Iss. 1, 2007-02 , pp. 69-75

Springer Publishing Company

Abstract Access to resources Recommend Favorite